Investimentos Corp. acquired 8.2% stake of EastPharma Ltd. (LSE:EAST) from D.E. Shaw Laminar Portfolios, LLC on September 6, 2018. Under the transaction, Investimentos Corp. acquired 5.5 million shares, representing 8.2% of the issued share capital of the EastPharma. Following the acquisition, Philipp Haas, Chairman and Chief Executive Officer of the EastPharma holds 0.9% of the issued share capital of the EastPharma and subject to trustee discretion may beneficially hold a further interest of up to 8.2% of the issued share capital of the EastPharma. Investimentos Corp. completed the acquisition of 8.2% stake in EastPharma Ltd. (LSE:EAST) from D.E. Shaw Laminar Portfolios, LLC on September 6, 2018.